Research points to development of single vaccine for Chikungunya, related viruses​

November 10, 2015 by Tamara Bhandari, Washington University School of Medicine in St. Louis
Research points to development of single vaccine for Chikungunya, related viruses​
Washington University researchers have identified “broadly neutralizing” antibodies that protect against infection by multiple, distantly related alphaviruses – including Chikungunya virus (above) – that cause fever and debilitating joint pain. Shown is a cryoelectron microscopy reconstruction of the Chikungunya virus. Credit: Wikimedia User A2-33

What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.

Researchers at Washington University School of Medicine in St. Louis have identified "broadly neutralizing" antibodies that protect against infection by multiple, distantly related alphaviruses – including Chikungunya virus – that cause fever and debilitating . The discovery, in mice, lays the groundwork for a single vaccine or antibody-based treatment against many different alphaviruses.

"There is a lot of emphasis on identifying and understanding for other viruses—HIV, hepatitis C virus, dengue virus, influenza virus—but most of those antibodies neutralize different strains of the same virus," said senior author Michael Diamond, MD, PhD, a professor of medicine and director of the Division of Infectious Diseases and Vaccine Development in the Center for Human Immunology and Immunotherapy Programs. "What we've identified here are antibodies that actually neutralize several different alphaviruses."

The research is available online in the journal Cell and will appear in the Nov. 19 print issue.

The viruses Diamond and colleagues studied are arthritogenic alphaviruses, so-named for their characteristic symptoms of fever followed by arthritis-like joint pain. These mosquito-borne viruses typically cause only sporadic outbreaks, although Chikungunya has been identified in Africa, Asia, Europe, South America and even the southern United States.

In recent years, the virus has caused millions of infections annually across the globe. So far in 2015, 650 cases have been seen in U.S. residents, largely among travelers returning from the Caribbean, where they were infected. There is no vaccine or treatment for Chikungunya or other alphaviruses.

As part of the study, Diamond and his colleagues screened 60 neutralizing mouse and against Chikungunya and determined that 10 react against three or more different alphaviruses that cause arthritis-like symptoms. They also identified a small piece of the alphavirus called an epitope that is identical across the arthritogenic alphavirus family.

In follow-up work in cell cultures, they showed that antibodies that recognize this epitope also protect against infection by multiple alphaviruses. The antibodies blocked multiple steps in the viral life cycle, including the virus's ability to enter or exit host cells.

To confirm that the antibodies could protect animals from disease, the researchers infected mice with three different alphaviruses: Chikungunya, the closely related O'nyong'nyong virus, or the more distantly related Mayaro virus. The mice then were treated with the each of two of the most potent broadly , and both antibodies markedly reduced joint disease caused by any of the viruses.

The researchers then identified a section of an alphavirus protein as the key binding site for the cross-protective antibodies. When such an antibody binds to this site, it changes the three-dimensional structure of the proteins on the surface of the virus, thus providing an explanation for how these antibodies prevent viral infection.

"If you can make an antibody response against this region, you may be able to protect against many viruses in the family," said Diamond. "Our group is making proteins now that focus on this epitope, and we're planning to start immunizing animals soon to see if we generate the right kinds of antibodies."

People who are infected with alphaviruses produce antibodies against many viral epitopes, some of which are not protective. This could lead to a weak immune response that gives the time to multiply and cause disease. People who are immunized with proteins expressing the key epitope identified by the researchers, however, should be able to quickly produce the "right" protective , thereby short-circuiting the disease process.

"We have more work to do but are encouraged that targeting this epitope could be a viable strategy for developing vaccines or treatments against Chikungunya and other related viruses that cause significant disease worldwide," Diamond said.

Explore further: Chikungunya test also distinguishes the illness from other mosquito-borne diseases

More information: Julie M. Fox et al. Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress, Cell (2015). DOI: 10.1016/j.cell.2015.10.050

Related Stories

Chikungunya test also distinguishes the illness from other mosquito-borne diseases

October 21, 2015
A detection assay that identifies the presence of viral-specific antibodies in patients with Chikungunya virus (CHIKV) has been developed by A*STAR researchers. The technique can also help differentiate between CHIKV and ...

New study has important implications for the design of a protective HIV vaccine

October 13, 2015
A PhD student from the University of the Witwatersrand today, 12 October 2015, published a study in the prestigious journal, Nature Medicine, describing how the changing viral swarm in an HIV infected person can drive the ...

New approach to tackle alphavirus infections

February 24, 2015
Griffith University and an international team of researchers have moved a step closer to identifying a broad spectrum treatment for the dreaded arthritogenic alphavirus infections.

Researchers model alternate ideas for an HIV vaccine

September 18, 2015
Scientists at Los Alamos National Laboratory have created a computational model that could change the way that researchers look at possibilities for an HIV-1 vaccine.

Research reveals how antibodies neutralize mosquito-borne virus

April 2, 2013
Researchers have learned the precise structure of the mosquito-transmitted chikungunya virus pathogen while it is bound to antibodies, showing how the infection is likely neutralized.

An antibody that can attack HIV in new ways

September 11, 2015
Proteins called broadly neutralizing antibodies (bNAbs) are a promising key to the prevention of infection by HIV, the virus that causes AIDS. bNAbs have been found in blood samples from some HIV patients whose immune systems ...

Recommended for you

Synthetic sandalwood found to prolong human hair growth

September 19, 2018
A team of researchers led by Ralf Paus of the University of Manchester has found that applying sandalwood to the scalp can prolong human hair growth. In their paper published in the journal Nature Communications, the group ...

Separated entry and exit doors for calcium keep energy production smooth in the powerhouses of heart cells

September 18, 2018
Stress demands the heart to work harder and faster. To keep pace, the muscle must make its fuel at an accelerated rate. Bursts of calcium entering mitochondria—the cell's powerhouses—normally help control energy output, ...

First gut bacteria may have lasting effect on ability to fight chronic diseases

September 18, 2018
New research showing that the first bacteria introduced into the gut have a lasting impact may one day allow science to adjust microbiomes—the one-of-a-kind microbial communities that live in our gastrointestinal tracts—to ...

A new defender for your sense of smell

September 18, 2018
New research from the Monell Center increases understanding of a mysterious sensory cell located in the olfactory epithelium, the patch of nasal tissue that contains odor-detecting olfactory receptor cells. The findings suggest ...

Small molecule plays big role in weaker bones as we age

September 18, 2018
With age, expression of a small molecule that can silence others goes way up while a key signaling molecule that helps stem cells make healthy bone goes down, scientists report.

Sperm quality study updates advice for couples trying to conceive

September 17, 2018
Could doctors at fertility clinics be giving men bad advice? Dr. Da Li and Dr. XiuXia Wang, who are clinician-researchers at the Center for Reproductive Medicine of Shengjing Hospital in Shenyang in northeast China, think ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.